nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Cytochrome P450 2C19 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.638	1	CiPCiCtD
Esomeprazole—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0224	0.0923	CbGbCtD
Esomeprazole—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0211	0.0868	CbGbCtD
Esomeprazole—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0191	0.0785	CbGbCtD
Esomeprazole—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0191	0.0785	CbGbCtD
Esomeprazole—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0165	0.0678	CbGbCtD
Esomeprazole—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.016	0.0658	CbGbCtD
Esomeprazole—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0595	CbGbCtD
Esomeprazole—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.0595	CbGbCtD
Esomeprazole—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0139	0.057	CbGbCtD
Esomeprazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0108	0.0446	CbGbCtD
Esomeprazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0102	0.042	CbGbCtD
Esomeprazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0102	0.042	CbGbCtD
Esomeprazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00922	0.038	CbGbCtD
Esomeprazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00922	0.038	CbGbCtD
Esomeprazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00796	0.0328	CbGbCtD
Esomeprazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00773	0.0318	CbGbCtD
Esomeprazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00699	0.0288	CbGbCtD
Esomeprazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00699	0.0288	CbGbCtD
Esomeprazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0067	0.0276	CbGbCtD
Esomeprazole—ATP4A—blood plasma—acquired immunodeficiency syndrome	0.00219	0.215	CbGeAlD
Esomeprazole—ATP4B—digestive system—acquired immunodeficiency syndrome	0.00194	0.19	CbGeAlD
Esomeprazole—ATP4A—digestive system—acquired immunodeficiency syndrome	0.000844	0.0826	CbGeAlD
Esomeprazole—ATP4A—blood—acquired immunodeficiency syndrome	0.000804	0.0787	CbGeAlD
Esomeprazole—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000766	0.075	CbGeAlD
Esomeprazole—ATP4A—nervous system—acquired immunodeficiency syndrome	0.000653	0.0639	CbGeAlD
Esomeprazole—ATP4A—central nervous system—acquired immunodeficiency syndrome	0.000628	0.0615	CbGeAlD
Esomeprazole—ATP4A—brain—acquired immunodeficiency syndrome	0.000499	0.0488	CbGeAlD
Esomeprazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000453	0.0443	CbGeAlD
Esomeprazole—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000295	0.0288	CbGeAlD
Esomeprazole—CYP2C19—blood—acquired immunodeficiency syndrome	0.000281	0.0275	CbGeAlD
Esomeprazole—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00026	0.0255	CbGeAlD
Esomeprazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000174	0.0171	CbGeAlD
Esomeprazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000166	0.0162	CbGeAlD
Esomeprazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000135	0.0132	CbGeAlD
Esomeprazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00013	0.0127	CbGeAlD
Esomeprazole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	4.5e-05	0.000412	CcSEcCtD
Esomeprazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	4.5e-05	0.000411	CcSEcCtD
Esomeprazole—Asthenia—Abacavir—acquired immunodeficiency syndrome	4.49e-05	0.000411	CcSEcCtD
Esomeprazole—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	4.49e-05	0.00041	CcSEcCtD
Esomeprazole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.00041	CcSEcCtD
Esomeprazole—Chest pain—Ritonavir—acquired immunodeficiency syndrome	4.48e-05	0.00041	CcSEcCtD
Esomeprazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	4.48e-05	0.00041	CcSEcCtD
Esomeprazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	4.48e-05	0.00041	CcSEcCtD
Esomeprazole—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	4.46e-05	0.000408	CcSEcCtD
Esomeprazole—Anaemia—Lamivudine—acquired immunodeficiency syndrome	4.46e-05	0.000408	CcSEcCtD
Esomeprazole—Anxiety—Ritonavir—acquired immunodeficiency syndrome	4.46e-05	0.000408	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	4.45e-05	0.000407	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	4.43e-05	0.000406	CcSEcCtD
Esomeprazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	4.43e-05	0.000405	CcSEcCtD
Esomeprazole—Fatigue—Indinavir—acquired immunodeficiency syndrome	4.43e-05	0.000405	CcSEcCtD
Esomeprazole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	4.43e-05	0.000405	CcSEcCtD
Esomeprazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	4.42e-05	0.000405	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	4.42e-05	0.000404	CcSEcCtD
Esomeprazole—Cough—Saquinavir—acquired immunodeficiency syndrome	4.42e-05	0.000404	CcSEcCtD
Esomeprazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000404	CcSEcCtD
Esomeprazole—Pain—Indinavir—acquired immunodeficiency syndrome	4.39e-05	0.000402	CcSEcCtD
Esomeprazole—Constipation—Indinavir—acquired immunodeficiency syndrome	4.39e-05	0.000402	CcSEcCtD
Esomeprazole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	4.39e-05	0.000401	CcSEcCtD
Esomeprazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	4.39e-05	0.000401	CcSEcCtD
Esomeprazole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	4.38e-05	0.000401	CcSEcCtD
Esomeprazole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	4.37e-05	0.0004	CcSEcCtD
Esomeprazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	4.37e-05	0.000399	CcSEcCtD
Esomeprazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	4.37e-05	0.000399	CcSEcCtD
Esomeprazole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	4.36e-05	0.000399	CcSEcCtD
Esomeprazole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	4.36e-05	0.000398	CcSEcCtD
Esomeprazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	4.36e-05	0.000398	CcSEcCtD
Esomeprazole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	4.35e-05	0.000398	CcSEcCtD
Esomeprazole—Nausea—Didanosine—acquired immunodeficiency syndrome	4.35e-05	0.000398	CcSEcCtD
Esomeprazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	4.34e-05	0.000397	CcSEcCtD
Esomeprazole—Confusional state—Ritonavir—acquired immunodeficiency syndrome	4.33e-05	0.000396	CcSEcCtD
Esomeprazole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	4.33e-05	0.000396	CcSEcCtD
Esomeprazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	4.32e-05	0.000395	CcSEcCtD
Esomeprazole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	4.31e-05	0.000395	CcSEcCtD
Esomeprazole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	4.31e-05	0.000394	CcSEcCtD
Esomeprazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	4.31e-05	0.000394	CcSEcCtD
Esomeprazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	4.31e-05	0.000394	CcSEcCtD
Esomeprazole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	4.3e-05	0.000393	CcSEcCtD
Esomeprazole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	4.28e-05	0.000392	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	4.28e-05	0.000392	CcSEcCtD
Esomeprazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	4.27e-05	0.000391	CcSEcCtD
Esomeprazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	4.26e-05	0.00039	CcSEcCtD
Esomeprazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	4.23e-05	0.000387	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	4.23e-05	0.000387	CcSEcCtD
Esomeprazole—Shock—Ritonavir—acquired immunodeficiency syndrome	4.22e-05	0.000386	CcSEcCtD
Esomeprazole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	4.22e-05	0.000386	CcSEcCtD
Esomeprazole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	4.22e-05	0.000386	CcSEcCtD
Esomeprazole—Cough—Lamivudine—acquired immunodeficiency syndrome	4.21e-05	0.000385	CcSEcCtD
Esomeprazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	4.21e-05	0.000385	CcSEcCtD
Esomeprazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	4.21e-05	0.000385	CcSEcCtD
Esomeprazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	4.2e-05	0.000384	CcSEcCtD
Esomeprazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	4.2e-05	0.000384	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	4.2e-05	0.000384	CcSEcCtD
Esomeprazole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000384	CcSEcCtD
Esomeprazole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	4.19e-05	0.000383	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	4.19e-05	0.000383	CcSEcCtD
Esomeprazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	4.18e-05	0.000383	CcSEcCtD
Esomeprazole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	4.18e-05	0.000383	CcSEcCtD
Esomeprazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	4.17e-05	0.000381	CcSEcCtD
Esomeprazole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	4.17e-05	0.000381	CcSEcCtD
Esomeprazole—Confusional state—Saquinavir—acquired immunodeficiency syndrome	4.17e-05	0.000381	CcSEcCtD
Esomeprazole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	4.15e-05	0.00038	CcSEcCtD
Esomeprazole—Constipation—Efavirenz—acquired immunodeficiency syndrome	4.15e-05	0.00038	CcSEcCtD
Esomeprazole—Pain—Efavirenz—acquired immunodeficiency syndrome	4.15e-05	0.00038	CcSEcCtD
Esomeprazole—Rash—Nevirapine—acquired immunodeficiency syndrome	4.15e-05	0.000379	CcSEcCtD
Esomeprazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	4.15e-05	0.000379	CcSEcCtD
Esomeprazole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	4.14e-05	0.000379	CcSEcCtD
Esomeprazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	4.14e-05	0.000379	CcSEcCtD
Esomeprazole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	4.13e-05	0.000377	CcSEcCtD
Esomeprazole—Headache—Nevirapine—acquired immunodeficiency syndrome	4.12e-05	0.000377	CcSEcCtD
Esomeprazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.000376	CcSEcCtD
Esomeprazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.000376	CcSEcCtD
Esomeprazole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.000376	CcSEcCtD
Esomeprazole—Infection—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000375	CcSEcCtD
Esomeprazole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	4.1e-05	0.000375	CcSEcCtD
Esomeprazole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	4.09e-05	0.000374	CcSEcCtD
Esomeprazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	4.09e-05	0.000374	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000374	CcSEcCtD
Esomeprazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	4.08e-05	0.000373	CcSEcCtD
Esomeprazole—Shock—Saquinavir—acquired immunodeficiency syndrome	4.07e-05	0.000372	CcSEcCtD
Esomeprazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	4.06e-05	0.000372	CcSEcCtD
Esomeprazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	4.06e-05	0.000371	CcSEcCtD
Esomeprazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	4.06e-05	0.000371	CcSEcCtD
Esomeprazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	4.05e-05	0.000371	CcSEcCtD
Esomeprazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	4.05e-05	0.000371	CcSEcCtD
Esomeprazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	4.05e-05	0.00037	CcSEcCtD
Esomeprazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	4.04e-05	0.000369	CcSEcCtD
Esomeprazole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	4.04e-05	0.000369	CcSEcCtD
Esomeprazole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	4.02e-05	0.000368	CcSEcCtD
Esomeprazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	4.02e-05	0.000368	CcSEcCtD
Esomeprazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	4.01e-05	0.000367	CcSEcCtD
Esomeprazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	4.01e-05	0.000367	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	4.01e-05	0.000367	CcSEcCtD
Esomeprazole—Rash—Stavudine—acquired immunodeficiency syndrome	4.01e-05	0.000366	CcSEcCtD
Esomeprazole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	4e-05	0.000366	CcSEcCtD
Esomeprazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	4e-05	0.000366	CcSEcCtD
Esomeprazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	4e-05	0.000366	CcSEcCtD
Esomeprazole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.000365	CcSEcCtD
Esomeprazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.99e-05	0.000365	CcSEcCtD
Esomeprazole—Headache—Stavudine—acquired immunodeficiency syndrome	3.98e-05	0.000364	CcSEcCtD
Esomeprazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.98e-05	0.000364	CcSEcCtD
Esomeprazole—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.97e-05	0.000364	CcSEcCtD
Esomeprazole—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.97e-05	0.000363	CcSEcCtD
Esomeprazole—Pain—Delavirdine—acquired immunodeficiency syndrome	3.97e-05	0.000363	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.97e-05	0.000363	CcSEcCtD
Esomeprazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.96e-05	0.000362	CcSEcCtD
Esomeprazole—Rash—Abacavir—acquired immunodeficiency syndrome	3.95e-05	0.000361	CcSEcCtD
Esomeprazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.94e-05	0.000361	CcSEcCtD
Esomeprazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.94e-05	0.000361	CcSEcCtD
Esomeprazole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.94e-05	0.00036	CcSEcCtD
Esomeprazole—Headache—Abacavir—acquired immunodeficiency syndrome	3.92e-05	0.000359	CcSEcCtD
Esomeprazole—Infection—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000358	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.91e-05	0.000358	CcSEcCtD
Esomeprazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.91e-05	0.000357	CcSEcCtD
Esomeprazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.91e-05	0.000357	CcSEcCtD
Esomeprazole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000355	CcSEcCtD
Esomeprazole—Shock—Lamivudine—acquired immunodeficiency syndrome	3.88e-05	0.000355	CcSEcCtD
Esomeprazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.87e-05	0.000354	CcSEcCtD
Esomeprazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.86e-05	0.000353	CcSEcCtD
Esomeprazole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.86e-05	0.000353	CcSEcCtD
Esomeprazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.85e-05	0.000353	CcSEcCtD
Esomeprazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.84e-05	0.000351	CcSEcCtD
Esomeprazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.84e-05	0.000351	CcSEcCtD
Esomeprazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.83e-05	0.00035	CcSEcCtD
Esomeprazole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.83e-05	0.00035	CcSEcCtD
Esomeprazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.83e-05	0.00035	CcSEcCtD
Esomeprazole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.82e-05	0.000349	CcSEcCtD
Esomeprazole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000349	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.000347	CcSEcCtD
Esomeprazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.79e-05	0.000346	CcSEcCtD
Esomeprazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.78e-05	0.000346	CcSEcCtD
Esomeprazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.78e-05	0.000346	CcSEcCtD
Esomeprazole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.78e-05	0.000346	CcSEcCtD
Esomeprazole—Nausea—Stavudine—acquired immunodeficiency syndrome	3.77e-05	0.000345	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.76e-05	0.000344	CcSEcCtD
Esomeprazole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.76e-05	0.000344	CcSEcCtD
Esomeprazole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.74e-05	0.000342	CcSEcCtD
Esomeprazole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.73e-05	0.000341	CcSEcCtD
Esomeprazole—Nausea—Abacavir—acquired immunodeficiency syndrome	3.72e-05	0.00034	CcSEcCtD
Esomeprazole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.71e-05	0.000339	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.000339	CcSEcCtD
Esomeprazole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.7e-05	0.000339	CcSEcCtD
Esomeprazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.69e-05	0.000337	CcSEcCtD
Esomeprazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.000337	CcSEcCtD
Esomeprazole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.68e-05	0.000337	CcSEcCtD
Esomeprazole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.67e-05	0.000336	CcSEcCtD
Esomeprazole—Pain—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.000336	CcSEcCtD
Esomeprazole—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.000336	CcSEcCtD
Esomeprazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.67e-05	0.000336	CcSEcCtD
Esomeprazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.67e-05	0.000336	CcSEcCtD
Esomeprazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.65e-05	0.000334	CcSEcCtD
Esomeprazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.64e-05	0.000333	CcSEcCtD
Esomeprazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.63e-05	0.000332	CcSEcCtD
Esomeprazole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.59e-05	0.000329	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.59e-05	0.000328	CcSEcCtD
Esomeprazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3.57e-05	0.000327	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.000326	CcSEcCtD
Esomeprazole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.57e-05	0.000326	CcSEcCtD
Esomeprazole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.56e-05	0.000326	CcSEcCtD
Esomeprazole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3.54e-05	0.000324	CcSEcCtD
Esomeprazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	3.54e-05	0.000324	CcSEcCtD
Esomeprazole—Pain—Saquinavir—acquired immunodeficiency syndrome	3.53e-05	0.000323	CcSEcCtD
Esomeprazole—Constipation—Saquinavir—acquired immunodeficiency syndrome	3.53e-05	0.000323	CcSEcCtD
Esomeprazole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	3.51e-05	0.000321	CcSEcCtD
Esomeprazole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	3.51e-05	0.000321	CcSEcCtD
Esomeprazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	3.51e-05	0.000321	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	3.51e-05	0.000321	CcSEcCtD
Esomeprazole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	3.5e-05	0.000321	CcSEcCtD
Esomeprazole—Rash—Zidovudine—acquired immunodeficiency syndrome	3.48e-05	0.000318	CcSEcCtD
Esomeprazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.000318	CcSEcCtD
Esomeprazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.48e-05	0.000318	CcSEcCtD
Esomeprazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	3.47e-05	0.000317	CcSEcCtD
Esomeprazole—Headache—Zidovudine—acquired immunodeficiency syndrome	3.46e-05	0.000316	CcSEcCtD
Esomeprazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.43e-05	0.000314	CcSEcCtD
Esomeprazole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.43e-05	0.000313	CcSEcCtD
Esomeprazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.42e-05	0.000313	CcSEcCtD
Esomeprazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.41e-05	0.000312	CcSEcCtD
Esomeprazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.41e-05	0.000311	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.4e-05	0.000311	CcSEcCtD
Esomeprazole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.4e-05	0.000311	CcSEcCtD
Esomeprazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.000311	CcSEcCtD
Esomeprazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.00031	CcSEcCtD
Esomeprazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.00031	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000309	CcSEcCtD
Esomeprazole—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000308	CcSEcCtD
Esomeprazole—Pain—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000308	CcSEcCtD
Esomeprazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.000305	CcSEcCtD
Esomeprazole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.32e-05	0.000304	CcSEcCtD
Esomeprazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	3.28e-05	0.0003	CcSEcCtD
Esomeprazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	3.28e-05	0.0003	CcSEcCtD
Esomeprazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	3.28e-05	0.0003	CcSEcCtD
Esomeprazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000299	CcSEcCtD
Esomeprazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000299	CcSEcCtD
Esomeprazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	3.27e-05	0.000299	CcSEcCtD
Esomeprazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000297	CcSEcCtD
Esomeprazole—Rash—Indinavir—acquired immunodeficiency syndrome	3.24e-05	0.000296	CcSEcCtD
Esomeprazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	3.24e-05	0.000296	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000295	CcSEcCtD
Esomeprazole—Headache—Indinavir—acquired immunodeficiency syndrome	3.22e-05	0.000294	CcSEcCtD
Esomeprazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	3.21e-05	0.000293	CcSEcCtD
Esomeprazole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.18e-05	0.000291	CcSEcCtD
Esomeprazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.16e-05	0.000289	CcSEcCtD
Esomeprazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.000286	CcSEcCtD
Esomeprazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.000285	CcSEcCtD
Esomeprazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.000285	CcSEcCtD
Esomeprazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.09e-05	0.000282	CcSEcCtD
Esomeprazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000282	CcSEcCtD
Esomeprazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	3.07e-05	0.000281	CcSEcCtD
Esomeprazole—Rash—Efavirenz—acquired immunodeficiency syndrome	3.06e-05	0.00028	CcSEcCtD
Esomeprazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.06e-05	0.00028	CcSEcCtD
Esomeprazole—Nausea—Indinavir—acquired immunodeficiency syndrome	3.05e-05	0.000279	CcSEcCtD
Esomeprazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.04e-05	0.000278	CcSEcCtD
Esomeprazole—Headache—Efavirenz—acquired immunodeficiency syndrome	3.04e-05	0.000278	CcSEcCtD
Esomeprazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.04e-05	0.000278	CcSEcCtD
Esomeprazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000271	CcSEcCtD
Esomeprazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.95e-05	0.00027	CcSEcCtD
Esomeprazole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.94e-05	0.000269	CcSEcCtD
Esomeprazole—Rash—Delavirdine—acquired immunodeficiency syndrome	2.93e-05	0.000268	CcSEcCtD
Esomeprazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.92e-05	0.000267	CcSEcCtD
Esomeprazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.92e-05	0.000267	CcSEcCtD
Esomeprazole—Headache—Delavirdine—acquired immunodeficiency syndrome	2.91e-05	0.000266	CcSEcCtD
Esomeprazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.9e-05	0.000266	CcSEcCtD
Esomeprazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.88e-05	0.000264	CcSEcCtD
Esomeprazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.84e-05	0.00026	CcSEcCtD
Esomeprazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000259	CcSEcCtD
Esomeprazole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.83e-05	0.000259	CcSEcCtD
Esomeprazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.79e-05	0.000255	CcSEcCtD
Esomeprazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.76e-05	0.000252	CcSEcCtD
Esomeprazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.73e-05	0.00025	CcSEcCtD
Esomeprazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.73e-05	0.00025	CcSEcCtD
Esomeprazole—Rash—Ritonavir—acquired immunodeficiency syndrome	2.71e-05	0.000248	CcSEcCtD
Esomeprazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.7e-05	0.000247	CcSEcCtD
Esomeprazole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.7e-05	0.000247	CcSEcCtD
Esomeprazole—Headache—Ritonavir—acquired immunodeficiency syndrome	2.69e-05	0.000246	CcSEcCtD
Esomeprazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.63e-05	0.00024	CcSEcCtD
Esomeprazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000238	CcSEcCtD
Esomeprazole—Rash—Saquinavir—acquired immunodeficiency syndrome	2.61e-05	0.000238	CcSEcCtD
Esomeprazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.6e-05	0.000238	CcSEcCtD
Esomeprazole—Headache—Saquinavir—acquired immunodeficiency syndrome	2.59e-05	0.000237	CcSEcCtD
Esomeprazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.55e-05	0.000233	CcSEcCtD
Esomeprazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.51e-05	0.000229	CcSEcCtD
Esomeprazole—Rash—Lamivudine—acquired immunodeficiency syndrome	2.49e-05	0.000227	CcSEcCtD
Esomeprazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.48e-05	0.000227	CcSEcCtD
Esomeprazole—Headache—Lamivudine—acquired immunodeficiency syndrome	2.47e-05	0.000226	CcSEcCtD
Esomeprazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.45e-05	0.000224	CcSEcCtD
Esomeprazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.34e-05	0.000214	CcSEcCtD
